NCT00288223View on ClinicalTrials.gov

Telithromycin in Acute Exacerbation of Chronic Bronchitis

PHASE4TerminatedINTERVENTIONAL

Enrollment

54

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions

Bronchitis, Chronic

Interventions

DRUG

Telithromycin

one daily intake of 800 mg (i.e. 2 x 400 mg tablets) per os in a single intake with a meal for 5 days.

Trial Locations (1)

Unknown

Sanofi-Aventis, Istanbul

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY